ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Change of Director's Interest Notice		29/06/18	598.7KB	Share
AVR	Appendix 3B		29/06/18	804.65KB	Share
AVR	Results of Extraordinary General Meeting		28/06/18	82.2KB	Share
AVR	MOU signed for Admedus Vaccines	PRICE SENSITIVE	27/06/18	633.37KB	Share
AVR	Reciept of Placement Funds from Directors		21/06/18	76.58KB	Share
AVR	Change of Director's Interest Notices		08/06/18	386.86KB	Share
AVR	Appendix 3B		08/06/18	816.46KB	Share
AVR	Conclusion of relationship with Go Medical Industries	PRICE SENSITIVE	07/06/18	83.13KB	Share
AVR	Trading Halt	PRICE SENSITIVE	06/06/18	104.88KB	Share
AVR	Share Purchase Plan Results		04/06/18	438.02KB	Share
AVR	Notice of EGM/Proxy Form		29/05/18	507.39KB	Share
AVR	Confirmation of Grant of ASX Waiver		29/05/18	59.78KB	Share
AVR	Initial Director's Interest Notice - Catherine Costello		24/05/18	62.87KB	Share
AVR	Results of 2017 (July - Dec) AGM		24/05/18	85.27KB	Share
AVR	Director Re-Appointment - Catherine Costello		24/05/18	79.45KB	Share
AVR	Final Director's Interest Notice - Catherine Costello		24/05/18	60.32KB	Share
AVR	2017 AGM (July-Dec) - Chairman and CEO Presentation		24/05/18	5.33MB	Share
AVR	Initial Director's Interest Notice		23/05/18	62.64KB	Share
AVR	Appointment of Director	PRICE SENSITIVE	23/05/18	64.89KB	Share
AVR	Additional patents filed for TAVR device project	PRICE SENSITIVE	23/05/18	83.52KB	Share
AVR	Withdrawal of Resolution from AGM		22/05/18	74.02KB	Share
AVR	TAVR project progresses to animal trials	PRICE SENSITIVE	22/05/18	100KB	Share
AVR	Ceasing to be a substantial holder		21/05/18	130.02KB	Share
AVR	Director Resignation - Mathew Ratty		21/05/18	626.11KB	Share
AVR	Admedus enters distribution agreement for Spain	PRICE SENSITIVE	17/05/18	74.78KB	Share
AVR	Appendix 3B - Placement of shares		16/05/18	896.73KB	Share
AVR	Share Purchase Plan	PRICE SENSITIVE	10/05/18	902.27KB	Share
AVR	Cleansing Statement - SPP		10/05/18	129.67KB	Share
AVR	Admedus secures further funding with Placement and SPP	PRICE SENSITIVE	10/05/18	85.36KB	Share
AVR	Trading Halt	PRICE SENSITIVE	08/05/18	509.84KB	Share
AVR	Admedus appoints new Vice President - Development		01/05/18	95.49KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	139.54KB	Share
AVR	Investor signs Letter of Intent to fund Admedus Vaccines	PRICE SENSITIVE	27/04/18	74.84KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		20/04/18	997.56KB	Share
AVR	Appendix 4G		20/04/18	261.37KB	Share
AVR	Annual Report to shareholders		20/04/18	7.88MB	Share
AVR	Investor presentation		19/04/18	2.39MB	Share
AVR	Admedus TAVR gaining momentum with new patent applications	PRICE SENSITIVE	19/04/18	400.23KB	Share
AVR	Company Secretary Appointment/Resignation		15/03/18	381.04KB	Share
AVR	Admedus update on TAVR project	PRICE SENSITIVE	12/03/18	404.36KB	Share
AVR	Admedus contracts with US Group Purchasing Organisation	PRICE SENSITIVE	09/03/18	355.81KB	Share
AVR	CANADA REGULATORY APPROVAL GRANTED - CARDIOCEL 3D, VASCUCEL	PRICE SENSITIVE	07/03/18	408.44KB	Share
AVR	Appendix 4E & 31 December 2017 Financial Report	PRICE SENSITIVE	28/02/18	795.64KB	Share
AVR	Company Secretary Appointment/Resignation, Change of Address		27/02/18	386.73KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	691KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/18	632.92KB	Share
AVR	Appendix 3B - ESOP		20/12/17	961.18KB	Share
AVR	Change of Financial Year-End		11/12/17	252.52KB	Share
AVR	Regulatory approval to launch CardioCel in India	PRICE SENSITIVE	22/11/17	272.93KB	Share
AVR	Results of Meeting		16/11/17	291.11KB	Share
AVR	Address to Shareholders		16/11/17	7.14MB	Share
AVR	AGM Live Stream Webinar Registration Open		14/11/17	246.19KB	Share
AVR	Update on Admedus shaped patch product franchise	PRICE SENSITIVE	14/11/17	286.79KB	Share
AVR	AHZ RESPONDS TO MEDIA SPECULATION		02/11/17	161.73KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	210.45KB	Share
AVR	Notice under Section 708(A)(e) of the Corporations Act		26/10/17	262.57KB	Share
AVR	Appendix 3B		26/10/17	807.33KB	Share
AVR	Admedus announces facility agreement with PFG	PRICE SENSITIVE	26/10/17	368.25KB	Share
AVR	Trading Halt	PRICE SENSITIVE	24/10/17	285.57KB	Share
AVR	Admedus TAVR project on track with new IP application	PRICE SENSITIVE	24/10/17	269.42KB	Share
AVR	Notice of Annual General Meeting	PRICE SENSITIVE	13/10/17	276.01KB	Share
AVR	Appendix 4G		13/10/17	258.14KB	Share
AVR	Proxy Form		13/10/17	329.97KB	Share
AVR	Letter to Shareholders - Annual General Meeting		13/10/17	170.05KB	Share
AVR	Annual Report to shareholders		13/10/17	15.87MB	Share
AVR	Appendix 3B - ESOP		27/09/17	945.69KB	Share
AVR	Investor Webinar Presentation		05/09/17	4.81MB	Share
AVR	Investor Webinar		01/09/17	255.73KB	Share
AVR	Exclusive Supply Agreement with 4C Medical	PRICE SENSITIVE	31/08/17	122.12KB	Share
AVR	FY17 Full Year Results Announcement	PRICE SENSITIVE	31/08/17	593KB	Share
AVR	Appendix 4E & Preliminary Final Report	PRICE SENSITIVE	31/08/17	660.5KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/17	603.1KB	Share
AVR	Update on the CardioCel 3D Product Launch	PRICE SENSITIVE	07/07/17	144.38KB	Share
AVR	Admedus Appoints Chief Operating Officer		09/06/17	242.68KB	Share
AVR	Investor Presentation		25/05/17	2.15MB	Share
AVR	Appendix 3B		23/05/17	824.4KB	Share
AVR	Response to Aware Query	PRICE SENSITIVE	09/05/17	461.4KB	Share
AVR	Investor Webinar Presentation - HSV-2 Phase IIa Results		04/05/17	2.79MB	Share
AVR	Admedus Releases Results of HSV-2 Phase IIa Study	PRICE SENSITIVE	04/05/17	745.14KB	Share
AVR	Admedus Receives FDA Clearance for CardioCel 3D	PRICE SENSITIVE	02/05/17	516.73KB	Share
AVR	HSV-2 Phase IIa Results Investor Webinar		01/05/17	358.54KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/17	565.14KB	Share
AVR	Appendix 3B - ESOP		12/04/17	1.01MB	Share
AVR	Admedus Appoints Wayne Paterson as CEO	PRICE SENSITIVE	15/03/17	414.5KB	Share
AVR	Admedus Appoints John Seaberg as Chairman		14/03/17	408.25KB	Share
AVR	S&P DJ Indices Announces March Quarterly Rebalance	PRICE SENSITIVE	10/03/17	177.37KB	Share
AVR	Approval and first sales in Saudi Arabia	PRICE SENSITIVE	28/02/17	441.35KB	Share
AVR	Shareholder Webinar Presentation		28/02/17	4.29MB	Share
AVR	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/17	741.98KB	Share
AVR	Admedus Announces Half Yearly Report	PRICE SENSITIVE	24/02/17	626.68KB	Share
AVR	Final Director's Interest Notice		21/02/17	239.17KB	Share
AVR	Initial Director's Interest Notice		21/02/17	221.01KB	Share
AVR	Director Appointment/Resignation		17/02/17	422.86KB	Share
AVR	Shareholder Webinar		16/02/17	421.28KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	470.71KB	Share
AVR	Admedus Finishes 2016 with Growing Revenue	PRICE SENSITIVE	23/12/16	474.61KB	Share
AVR	Appendix 3Y		08/12/16	328.54KB	Share
AVR	Appendix 3B		08/12/16	1.03MB	Share
AVR	Appendix 3B		05/12/16	1.02MB	Share
AVR	Appendix 3B - ESOP		22/11/16	1.01MB	Share

AVR Change of Director's Interest Notice
29/06/18		598.7KB	Share
AVR Appendix 3B
29/06/18		804.65KB	Share
AVR Results of Extraordinary General Meeting
28/06/18		82.2KB	Share
AVR MOU signed for Admedus Vaccines
27/06/18	PRICE SENSITIVE	633.37KB	Share
AVR Reciept of Placement Funds from Directors
21/06/18		76.58KB	Share
AVR Change of Director's Interest Notices
08/06/18		386.86KB	Share
AVR Appendix 3B
08/06/18		816.46KB	Share
AVR Conclusion of relationship with Go Medical Industries
07/06/18	PRICE SENSITIVE	83.13KB	Share
AVR Trading Halt
06/06/18	PRICE SENSITIVE	104.88KB	Share
AVR Share Purchase Plan Results
04/06/18		438.02KB	Share
AVR Notice of EGM/Proxy Form
29/05/18		507.39KB	Share
AVR Confirmation of Grant of ASX Waiver
29/05/18		59.78KB	Share
AVR Initial Director's Interest Notice - Catherine Costello
24/05/18		62.87KB	Share
AVR Results of 2017 (July - Dec) AGM
24/05/18		85.27KB	Share
AVR Director Re-Appointment - Catherine Costello
24/05/18		79.45KB	Share
AVR Final Director's Interest Notice - Catherine Costello
24/05/18		60.32KB	Share
AVR 2017 AGM (July-Dec) - Chairman and CEO Presentation
24/05/18		5.33MB	Share
AVR Initial Director's Interest Notice
23/05/18		62.64KB	Share
AVR Appointment of Director
23/05/18	PRICE SENSITIVE	64.89KB	Share
AVR Additional patents filed for TAVR device project
23/05/18	PRICE SENSITIVE	83.52KB	Share
AVR Withdrawal of Resolution from AGM
22/05/18		74.02KB	Share
AVR TAVR project progresses to animal trials
22/05/18	PRICE SENSITIVE	100KB	Share
AVR Ceasing to be a substantial holder
21/05/18		130.02KB	Share
AVR Director Resignation - Mathew Ratty
21/05/18		626.11KB	Share
AVR Admedus enters distribution agreement for Spain
17/05/18	PRICE SENSITIVE	74.78KB	Share
AVR Appendix 3B - Placement of shares
16/05/18		896.73KB	Share
AVR Share Purchase Plan
10/05/18	PRICE SENSITIVE	902.27KB	Share
AVR Cleansing Statement - SPP
10/05/18		129.67KB	Share
AVR Admedus secures further funding with Placement and SPP
10/05/18	PRICE SENSITIVE	85.36KB	Share
AVR Trading Halt
08/05/18	PRICE SENSITIVE	509.84KB	Share
AVR Admedus appoints new Vice President - Development
01/05/18		95.49KB	Share
AVR Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	139.54KB	Share
AVR Investor signs Letter of Intent to fund Admedus Vaccines
27/04/18	PRICE SENSITIVE	74.84KB	Share
AVR Notice of Annual General Meeting/Proxy Form
20/04/18		997.56KB	Share
AVR Appendix 4G
20/04/18		261.37KB	Share
AVR Annual Report to shareholders
20/04/18		7.88MB	Share
AVR Investor presentation
19/04/18		2.39MB	Share
AVR Admedus TAVR gaining momentum with new patent applications
19/04/18	PRICE SENSITIVE	400.23KB	Share
AVR Company Secretary Appointment/Resignation
15/03/18		381.04KB	Share
AVR Admedus update on TAVR project
12/03/18	PRICE SENSITIVE	404.36KB	Share
AVR Admedus contracts with US Group Purchasing Organisation
09/03/18	PRICE SENSITIVE	355.81KB	Share
AVR CANADA REGULATORY APPROVAL GRANTED - CARDIOCEL 3D, VASCUCEL
07/03/18	PRICE SENSITIVE	408.44KB	Share
AVR Appendix 4E & 31 December 2017 Financial Report
28/02/18	PRICE SENSITIVE	795.64KB	Share
AVR Company Secretary Appointment/Resignation, Change of Address
27/02/18		386.73KB	Share
AVR Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	691KB	Share
AVR Appendix 4C - quarterly
30/01/18	PRICE SENSITIVE	632.92KB	Share
AVR Appendix 3B - ESOP
20/12/17		961.18KB	Share
AVR Change of Financial Year-End
11/12/17		252.52KB	Share
AVR Regulatory approval to launch CardioCel in India
22/11/17	PRICE SENSITIVE	272.93KB	Share
AVR Results of Meeting
16/11/17		291.11KB	Share
AVR Address to Shareholders
16/11/17		7.14MB	Share
AVR AGM Live Stream Webinar Registration Open
14/11/17		246.19KB	Share
AVR Update on Admedus shaped patch product franchise
14/11/17	PRICE SENSITIVE	286.79KB	Share
AVR AHZ RESPONDS TO MEDIA SPECULATION
02/11/17		161.73KB	Share
AVR Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	210.45KB	Share
AVR Notice under Section 708(A)(e) of the Corporations Act
26/10/17		262.57KB	Share
AVR Appendix 3B
26/10/17		807.33KB	Share
AVR Admedus announces facility agreement with PFG
26/10/17	PRICE SENSITIVE	368.25KB	Share
AVR Trading Halt
24/10/17	PRICE SENSITIVE	285.57KB	Share
AVR Admedus TAVR project on track with new IP application
24/10/17	PRICE SENSITIVE	269.42KB	Share
AVR Notice of Annual General Meeting
13/10/17	PRICE SENSITIVE	276.01KB	Share
AVR Appendix 4G
13/10/17		258.14KB	Share
AVR Proxy Form
13/10/17		329.97KB	Share
AVR Letter to Shareholders - Annual General Meeting
13/10/17		170.05KB	Share
AVR Annual Report to shareholders
13/10/17		15.87MB	Share
AVR Appendix 3B - ESOP
27/09/17		945.69KB	Share
AVR Investor Webinar Presentation
05/09/17		4.81MB	Share
AVR Investor Webinar
01/09/17		255.73KB	Share
AVR Exclusive Supply Agreement with 4C Medical
31/08/17	PRICE SENSITIVE	122.12KB	Share
AVR FY17 Full Year Results Announcement
31/08/17	PRICE SENSITIVE	593KB	Share
AVR Appendix 4E & Preliminary Final Report
31/08/17	PRICE SENSITIVE	660.5KB	Share
AVR Appendix 4C - quarterly
26/07/17	PRICE SENSITIVE	603.1KB	Share
AVR Update on the CardioCel 3D Product Launch
07/07/17	PRICE SENSITIVE	144.38KB	Share
AVR Admedus Appoints Chief Operating Officer
09/06/17		242.68KB	Share
AVR Investor Presentation
25/05/17		2.15MB	Share
AVR Appendix 3B
23/05/17		824.4KB	Share
AVR Response to Aware Query
09/05/17	PRICE SENSITIVE	461.4KB	Share
AVR Investor Webinar Presentation - HSV-2 Phase IIa Results
04/05/17		2.79MB	Share
AVR Admedus Releases Results of HSV-2 Phase IIa Study
04/05/17	PRICE SENSITIVE	745.14KB	Share
AVR Admedus Receives FDA Clearance for CardioCel 3D
02/05/17	PRICE SENSITIVE	516.73KB	Share
AVR HSV-2 Phase IIa Results Investor Webinar
01/05/17		358.54KB	Share
AVR Appendix 4C - quarterly
26/04/17	PRICE SENSITIVE	565.14KB	Share
AVR Appendix 3B - ESOP
12/04/17		1.01MB	Share
AVR Admedus Appoints Wayne Paterson as CEO
15/03/17	PRICE SENSITIVE	414.5KB	Share
AVR Admedus Appoints John Seaberg as Chairman
14/03/17		408.25KB	Share
AVR S&P DJ Indices Announces March Quarterly Rebalance
10/03/17	PRICE SENSITIVE	177.37KB	Share
AVR Approval and first sales in Saudi Arabia
28/02/17	PRICE SENSITIVE	441.35KB	Share
AVR Shareholder Webinar Presentation
28/02/17		4.29MB	Share
AVR Half Yearly Report and Accounts
24/02/17	PRICE SENSITIVE	741.98KB	Share
AVR Admedus Announces Half Yearly Report
24/02/17	PRICE SENSITIVE	626.68KB	Share
AVR Final Director's Interest Notice
21/02/17		239.17KB	Share
AVR Initial Director's Interest Notice
21/02/17		221.01KB	Share
AVR Director Appointment/Resignation
17/02/17		422.86KB	Share
AVR Shareholder Webinar
16/02/17		421.28KB	Share
AVR Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	470.71KB	Share
AVR Admedus Finishes 2016 with Growing Revenue
23/12/16	PRICE SENSITIVE	474.61KB	Share
AVR Appendix 3Y
08/12/16		328.54KB	Share
AVR Appendix 3B
08/12/16		1.03MB	Share
AVR Appendix 3B
05/12/16		1.02MB	Share
AVR Appendix 3B - ESOP
22/11/16		1.01MB	Share

REFRESH

First 6 7 8 9 10

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	613	5.240
1	576	5.200
1	20000	5.150
1	1000	5.110

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available